Health ❯ Clinical Trials

Phase 2 Trials

Cancer Treatments Medication Efficacy Weight Loss Drugs mRNA Technology VLA15-221 Study Drug Development Randomized Controlled Trials Male Birth Control Drug Efficacy Efficacy and Safety Vaccine Trials Hair Growth Studies Patient Dropout Rates Metabolic Dysfunction

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Validation now hinges on scaled randomized trials to confirm benefit.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion